Trials / Conditions / Congenital Myasthenic Syndrome

Congenital Myasthenic Syndrome

11 registered clinical trials studyying Congenital Myasthenic Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution NCT07226726	The Foundation for Orthopaedics and Regenerative Medicine	Phase 1
Recruiting	A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital NCT06436742	argenx	Phase 1
Recruiting	A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, M NCT06078553	argenx	—
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Completed	Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes NCT05408702	Institut de Myologie, France	—
Completed	Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes NCT01203592	Mayo Clinic	Phase 1
Completed	Pregnancy Outcomes in Congenital Myasthenie Syndrome NCT01474980	Institut de Myologie, France	—
Recruiting	Congenital Muscle Disease Study of Patient and Family Reported Medical Information NCT01403402	Cure CMD	—
No Longer Available	Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia NCT03062631	Ricardo Maselli	—
Approved For Marketing	Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myastheni NCT02189720	Catalyst Pharmaceuticals, Inc.	—
Approved For Marketing	3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS) NCT00872950	Lahey Clinic	—